Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr4.53 on revenue of kr30.01B. Analysts polled by Investing.com anticipated EPS of kr0.66 on revenue of kr4.7B.
Novo Nordisk ADR shares are up 12.46% from the beginning of the year and are trading at kr65.09 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on July 16, who reported EPS of kr1.67 on revenue of kr18.34B, compared to forecasts EPS of kr1.49 on revenue of kr17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of kr1.45 on revenue of kr15.27B, compared to forecast for EPS of kr1.42 on revenue of kr15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar